Invention Grant
- Patent Title: DNA-PK inhibitors
-
Application No.: US14205508Application Date: 2014-03-12
-
Publication No.: US09359380B2Publication Date: 2016-06-07
- Inventor: John Patrick Maxwell , Paul S. Charifson , Qing Tang , Steven M. Ronkin , Katrina Lee Jackson , Albert Charles Pierce , David J. Lauffer , Pan Li , Simon Giroux , Jinwang Xu , Kevin M. Cottrell , Mark A. Morris , Nathan D. Waal , John J. Court , Wenxin Gu , Hongbo Deng
- Applicant: Vertex Pharmaceuticals Incorporated
- Applicant Address: US MA Boston
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Boston
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07D498/00 ; C07D241/40 ; C07D405/12 ; C07D471/04 ; C07D417/12 ; C07D413/12 ; A61K31/506 ; A61K31/5377 ; A61K31/5386 ; C07D401/14 ; C07D403/12 ; C07D403/14 ; C07D405/14 ; C07D473/40 ; C07D475/00 ; C07D487/04 ; C07D491/048 ; C07D498/08 ; C07D241/42 ; C07D413/04 ; C07D241/44 ; C07D491/052
Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Public/Granted literature
- US20140275059A1 DNA-PK INHIBITORS Public/Granted day:2014-09-18
Information query
